Locsin, Fredie B.
HRN: 23-03-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2023
CEFTRIAXONE 1G (VIAL)
05/15/2023
05/22/2023
IV
2g
Q24h
For ORIF, Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes